#IV Therapy Analysis 2024

[karan777]

[amrutatbrc1]

Atenolol Market 2024-2033 : Demand, Trend, Segmentation, Forecast, Overview And Top Companies 

The atenolol global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Atenolol Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size -

The atenolol market size has grown strongly in recent years. It will grow from $11.05 billion in 2023 to $12.01 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased demand and consumption of antihypertensive drugs, increased patient pool of arrhythmia, and angina, increased prevalence of glaucoma, increased prevalence of arrhythmia, rise in online pharmacies.

The atenolol market size is expected to see strong growth in the next few years. It will grow to $15.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for atenolol, growing prevalence of hypertension, surging awareness regarding hypertension complexities, significant rise in the aged population, poor lifestyle and dietary habits. Major trends in the forecast period include demand for beta blockers, demand for beta-1 selective blockers, recent regulatory approvals for new formulations, development of extended-release formulations, demand for combination therapies.

Order your report now for swift delivery @

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers -

The growing prevalence of cardiovascular diseases is expected to propel the growth of the atenolol market going forward. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels. The growing prevalence of cardiovascular diseases is due to population growth and aging, risk factors, and lack of implementation of proven prevention and treatment strategies. Atenolol plays a crucial role in managing various cardiovascular diseases by reducing heart rate, lowering blood pressure, relieving angina symptoms, preventing heart attacks, and managing arrhythmias. It helps to stabilize heart function, control blood pressure, and prevent complications, contributing to better long-term cardiovascular health. For instance, in May 2022, according to the Centers for Disease Control and Prevention, a US-based governmental organization, the prevalence of coronary heart disease among adults aged 18 and over stood at 4.6% in 2020, experiencing a slight uptick to 4.9% in 2021. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the atenolol market.

The atenolol market covered in this report is segmented –

1) By Type: 98% Purity, 99% Purity

2) By Form: Tablets, IV Solution, Other Forms

3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies, Other Distribution Channels

4) By Application: Hypertension, Angina, Arrhythmia, Other Applications

Get an inside scoop of the atenolol market, Request now for Sample Report @

Regional Insights -

North America was the largest region in the atenolol market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atenolol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies -

Major companies operating in the atenolol market are <b>F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Abbott Laboratories Inc., Shanghai Pharmaceuticals Holding Co. Ltd., LGM Pharma, Torrent Pharmaceuticals GmbH, Cipla Inc., Intas Pharmaceuticals Limited, Lupin Limited, Macleods Pharmaceuticals Ltd., Ipca Laboratories Limited, Aristo Pharmaceuticals Pvt. Ltd, Medley Pharmaceuticals Ltd., Micro Labs Ltd., Unichem Laboratories Limited, Harman Finochem Ltd., Axplora, Erregierre SpA, Darou Pakhsh Pharma Chem Co., Zydus Pharmaceuticals (USA) Inc., Anant Pharmaceuticals Pvt. Ltd., Enomark LLC, Hairui Chemical, Octavius Pharma Pvt. Ltd., Hoventa Pharma</b>

Table of Contents

1. Executive Summary

2. Atenolol Market Report Structure

3. Atenolol Market Trends And Strategies

4. Atenolol Market – Macro Economic Scenario

5. Atenolol Market Size And Growth

…..

27. Atenolol Market Competitor Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

30. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[dermac1]

The Future of Cosmetic Dermatology: Trends to watch in 2024

The Future of Cosmetic Dermatology: Trends to watch in 2024

Numerous trends are expected to influence the future of cosmetic dermatology in 2024, putting the discipline on the verge of change. We are eager to investigate these developments at IV Drip in Model Town, Dermac Clinic in Model Town, New Delhi, since they hold the potential to improve patient care and treatment results.

1. Personalized Skincare Solutions

Our capacity to offer customized skincare is growing along with technology. Treatments catered to specific skin types and problems will become more popular in 2024. Dermatologists will be able to develop personalized regimens with the use of genetic testing and sophisticated skin analysis techniques, guaranteeing better outcomes and increased patient satisfaction.

2. Rise of Non-Invasive Procedures

Non-invasive cosmetic procedures are becoming more and more popular. Because of their efficiency and short recovery times, treatments including chemical peels, laser therapy, and microneedling are becoming more and more popular. Because these alternatives can produce obvious effects without requiring surgery, patients are choosing them more and more.

3. Integration of Artificial Intelligence

Dermatologists' methods for diagnosing and treating skin disorders are about to undergo a radical change because to artificial intelligence (AI). Dermac Clinic professionals may make well-informed decisions on treatment strategies thanks to AI's exceptional accuracy in analyzing photos of skin lesions. This technology not only enhances diagnostic precision but also streamlines patient care.

4. Emphasis on Preventative Care

In 2024, preventative skincare will be a key component of cosmetic dermatology. More patients are realizing how crucial early action is to preserving the health of their skin. Proactive treatment plans and routine skin exams can help stop problems like pigmentation, acne, and aging symptoms before they get worse.

5. Sustainable and Eco-Friendly Products

There is a discernible trend toward ecological skincare products as environmental consciousness rises. Consumers are increasingly looking for companies that value ethical sourcing and environmentally responsible operations. We anticipate that more clinics, including Dermac Clinic, will include sustainable practices into their services by 2024.

6. Advanced Laser Technologies

As laser technology advances, new gadgets provide increased safety and effectiveness for a range of therapies. New developments in laser technology will make surgeries like skin resurfacing and hair removal more enticing by giving patients quicker results and fewer side effects.

7. Holistic Approaches

Holistic techniques are increasingly being included into cosmetic dermatology. Patients are seeking therapies that enhance general wellbeing in addition to addressing superficial issues. This method involves integrating stress-reduction strategies, dietary advice, and lifestyle modifications with conventional dermatological treatments.

8. Virtual Consultations

Virtual consultations are here to stay, and the pandemic hastened the development of telemedicine. The convenience and accessibility of virtual consultations, which allow dermatologists to provide professional advise without requiring an in-person visit, will continue to benefit patients in 2024.

9. Focus on Mental Health

The connection between mental health and skin health is becoming more well acknowledged. Practitioners of cosmetic dermatology will focus more on comprehending patients' emotional requirements in relation to their skin concerns as the field develops. This all-encompassing strategy will create a more encouraging atmosphere for those pursuing treatment.

10. Expanded Treatment Options for Men

With more guys than ever before pursuing cosmetic dermatological treatments, the market for male grooming is growing quickly. More and more clinics will provide services designed especially for males, addressing issues including aging indications, acne scars, and hair loss.

Conclusion

Our goal at Dermac Clinic in Model Town, New Delhi, is to be on the cutting edge of these developments in cosmetic dermatology. Our objective is unwavering as we adopt new technologies and patient care techniques: to give our patients the best possible care that is tailored to their individual requirements.

We hope to improve your skincare experience and make sure you feel and look your best by monitoring these developing trends in 2024

[darkmaga-returns]

Protocol for cancer (doses below): 1)IV vit C ii) oral vit D iii) zinc iv) ivermectin v) Benzimidazoles & DON vi) zinc vii)dietary interventions (ketogenic diet, fasting viii) HBOT & physical activity

Dr. Paul Alexander

Oct 15, 2024

NEW JOM Template (isom.ca)

Marik is a giant and seeing him on deck gives me confidence. I have read in depth, studied the data and the enabling research and this should be added to the toolkit. If your doctors are throwing everything at your cancer then demand this and if they balk, change your doctors. You do what you must do to try to survive. It is your right!

Demand from your doctor:

‘The protocol should be followed for an average duration of 12 weeks, regardless of cancer type. The analysis of the interactions between each of the molecules revealed no contraindications to the combination of these substances (ANSM, 2023; CRAT, 2024; Lemberg, et al., 2018; Vidal, 2024). The treatment dosage and duration can be adjusted by the physician according to the individual patient, their ability to obtain the various molecules, and the treatment results.’

Researchers are reporting that ‘the mitochondrial-stem cell connection could be a key element in the therapeutic approach to cancer. In light of current knowledge, we have selected and propose the use of specific ortho-molecules, drugs and other therapies for their potential to revive cellular OxPhos activity, and target CSCs, glycolysis and glutaminolysis. These are also aimed at addressing metastases created by fusion hybridization between cancer stem cells and macrophages. Numerous experiments in cells, animals, and humans support the role of targeting the MSCC in both the prevention and treatment of cancer.’

Dosing and interventions and the magic is that all of this can be gotten OTC and done as lifestyle adjustments:

1.Intravenous Vitamin C Intermediate- and high-grade cancers: Dose of 1.5g/kg/day, 2-3x per week (Fan, et al., 2023). Established as a non-toxic dose for cancer patients (Wang, F., et al., 2019).

2. Oral Vitamin D All cancer grades: Dose of 50,000 IU/day for patients with a blood level ≤ 30ng/mL; 25,000 IU/day for levels 30-60ng/mL; and 5000 IU/day for levels 60-80ng/mL. Established as a non-toxic dose (Cannon, et al., 2016; Ghanaati, et al., 2020; McCullough, et al., 2019). It is necessary to reach a blood level of 80 ng/mL of vitamin D (25-hydroxyvitamine D (25(OH) D) (Kennel, et al., 2010; Mohr, et al., 2014; Mohr, et al., 2015). This level is non-toxic (Holick, et al., 2011). Once this level is reached it must be maintained with a reduced daily dosage of ≈ 2000 IU/day (Ekwaru, et al., 2014). The vitamin D blood concentration should be measured every two weeks for high doses and monthly for lower doses.

[credenceresearchdotblog]

The Peripheral Intravenous Catheter Market is projected to grow from USD 6,484.00 million in 2024 to USD 11,224.28 million by 2032, reflecting a compound annual growth rate (CAGR) of 7.10%.The global Peripheral Intravenous Catheter (PIVC) market has seen significant growth in recent years, driven by the increasing prevalence of chronic diseases, the aging population, and the rising demand for minimally invasive procedures. Peripheral Intravenous Catheters are small, flexible tubes inserted into a peripheral vein, typically in the arm or hand, to administer medications, fluids, or draw blood. These catheters are critical in healthcare settings, from emergency care to routine hospital procedures, making their market one of the essential segments in the medical devices industry.

Browse the full report at https://www.credenceresearch.com/report/peripheral-intravenous-catheter-market

Market Drivers

1. Rising Prevalence of Chronic Diseases The global burden of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, has been steadily increasing. These conditions often require long-term management, including regular intravenous (IV) therapy. The need for effective and reliable venous access devices, such as PIVCs, has thus become more pronounced. As healthcare systems across the world grapple with the growing demand for chronic disease management, the PIVC market is poised to benefit significantly.

2. Growing Geriatric Population The world is witnessing a demographic shift with an increasing number of elderly individuals. The aging population is more susceptible to chronic diseases and often requires repeated hospital visits, surgeries, and long-term care. This demographic trend is a key driver for the PIVC market, as elderly patients frequently need intravenous access for various treatments.

3. Advancements in Technology Innovations in catheter design and materials have enhanced the safety and efficacy of PIVCs. For instance, the development of safety-engineered catheters with features like retractable needles and closed systems has reduced the risk of needlestick injuries and infections. Furthermore, the use of advanced materials like polyurethane and silicone has improved catheter flexibility and patient comfort, driving the adoption of these devices in clinical settings.

4. Demand for Minimally Invasive Procedures There is a growing preference for minimally invasive procedures in the medical field, driven by their advantages, including reduced patient discomfort, shorter recovery times, and lower risks of complications. PIVCs play a crucial role in these procedures, providing reliable venous access with minimal trauma. The increasing adoption of minimally invasive techniques is, therefore, contributing to the expansion of the PIVC market.

Challenges and Opportunities

While the PIVC market is growing, it faces challenges such as the risk of catheter-related bloodstream infections (CRBSIs) and the high cost of advanced PIVCs. However, these challenges also present opportunities for innovation. Companies are investing in research and development to create PIVCs with improved safety features and infection control mechanisms. Additionally, the rise of home healthcare services is expected to open new avenues for market growth, particularly for portable and easy-to-use PIVCs.

Key Player Analysis

Terumo Corporation

R. Bard, Inc.

Teleflex Incorporated

Braun Melsungen AG

Argon Medical Devices, Inc.

Venner Medical

Vygon

Smiths Group plc.

NIPRO Medical Corporation

Becton, Dickinson, and Company

Segments:

Based on Product Type:

Short Peripheral IV Catheter

Ported PIVC

Non-Ported PIVC

Integrated/Closed PIVC

Closed with Extension Sets

Closed PIVC

Based on Technology:

Conventional PIVC

Safety PIVC

Closed with Extension Set

Active PIVC with Blood Control

Passive PIVC with Blood Control

Active PIVC

Passive PIVC

Based on End User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Clinics

Home Use

Others

Based on the Geography:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/peripheral-intravenous-catheter-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[tamanna31]

Home Infusion Therapy Market Size, Share, Growth, Analysis Forecast to 2030

Home Infusion Therapy Industry Overview

The global home infusion therapy market size was valued at USD 35.96 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030.

Home infusion therapy involves delivering therapeutic treatments, medications, or fluids directly into a patient's bloodstream through intravenous (IV) infusion, usually in the comfort and convenience of their home.

The growth of the market is driven by several key factors, including the expanding geriatric population characterized by decreased mobility, a rising preference for home care, and the swift evolution of technological advancements. Infusion therapy, encompassing essential components like IV therapy and IV hydration therapy, plays a crucial role in addressing conditions such as immune deficiencies, cancer, and congestive heart failure, where oral medication is not a viable treatment option. The increasing demand for these therapies stems from the need for long-term treatment among patients, positioning home infusion therapy as a notably cost-effective alternative to hospital-based care. The incorporation of IV therapy and IV hydration therapy serves as a driving force, providing patients with enhanced accessibility to effective and personalized medical solutions in the comfort of their homes

Gather more insights about the market drivers, restrains and growth of the Home Infusion Therapy Market

The home infusion market experienced a positive shift during the COVID-19 pandemic, with home infusion becoming a crucial necessity as healthcare facilities faced a surge in COVID patients. Despite the challenges posed by regional and country-wide lockdowns, causing disruptions in operations and supply chains, the market witnessed a substantial increase in 2020. As reported by Medtech Dive in October 2020, Baxter disclosed third-quarter sales of USD 2.97 billion, marking a 4% growth attributed to the rising demand for its COVID-related medical products. Furthermore, Baxter reported operational sales growth of 6% (reaching 3.2 billion) in Q3 2021 compared to 3.0 billion in Q3 2020, indicating a sustained recovery from the pandemic's impact.

Moreover, the market's expansion is propelled by the enhanced outcomes observed in patients and the cost-effectiveness and convenience provided by home infusion therapy. The increasing demographic of baby boomers struggling with diminished mobility due to conditions such as paralysis, osteoarthritis, and diabetes is expected to amplify the demand for home infusion therapy. The growing imperative to reduce the duration of inpatient stays is a pivotal factor poised to contribute significantly to the market's growth. Remarkably, continuous subcutaneous (SC) apomorphine infusion emerges as an exceptionally effective treatment for Parkinson's disease (PD), with diverse drug formulations available for the management of PD through subcutaneous delivery. In response to the mounting burden of PD, there is a notable surge in the demand for subcutaneous infusion therapy. For instance, in line with the Parkinson's Foundation's 2022 data update, approximately 90,000 individuals receive a PD diagnosis annually in the U.S. Furthermore, the anticipated number of people living with PD in the country is projected to soar to nearly 1.2 million by the year 2030.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global knee braces market size was valued at USD 1.12 billion in 2023 and is projected to grow at a CAGR of 7.7% from 2024 to 2030.

• The global western blotting market size was valued at USD 986.2 million in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2030.

Key Companies & Market Share Insights

Some of the key players operating in the market include Baxter, BD, Smiths Medical, Terumo Corporation, ICU Medical, etc

Baxter International Inc., commonly known as Baxter, is a global healthcare company that specializes in providing a wide range of medical products, therapies, and technologies. With a rich history dating back to the 1930s, Baxter has evolved into a leading player in the healthcare industry. The company develops innovative solutions for critical medical needs, including renal care, medication delivery, pharmaceuticals, and various therapeutic areas.

Becton, Dickinson and Company (BD) is a global medical technology company. BD specializes in developing and manufacturing medical devices, laboratory equipment, and diagnostic products aimed at advancing the diagnosis and treatment of various medical conditions. With a commitment to improving healthcare outcomes, BD focuses on delivering solutions in areas such as medication management, infection prevention, diagnostics, and biosciences.

Key Home Infusion Therapy Companies:

CVS/Coram

Option Care Health

BriovaRx/Diplomat (UnitedHealth Optum)

PharMerica

Fresenius Kabi

ICU Medical, Inc.

B. Braun Melsungen AG

Baxter

BD

Caesarea Medical Electronics

Smiths Medical

Terumo Corporation

JMS Co. Ltd.

Recent Developments

In June 2023, Baxter International, an American healthcare company, introduced Progressa+ Next Gen ICU bed for addressing critical needs of patients at their homes. This technology makes it easier for nurses to take care of patients, while supporting therapy at home.

In May 2023, Fresenius Kabi, a global healthcare company, initiated an agreement with Premier, Inc., an American healthcare company, that resulted in pricing and term benefits for the Ivenix Infusion System. This system is designed to advance the reliability and simplicity of infusion pumps.

In May 2023, Option Care Health, a healthcare service provider, created an independent platform for home care services in collaboration with Amedisys Inc., a leading provider of home health services. This platform comprises pharmacists, dieticians, therapists, social workers, and others for providing high quality healthcare services at home.

In April 2023, CareFusion, currently owned by Becton Dickinson, an American medical technology company, launched an advanced ultrasound technology to provide clinicians with optimal IV insertions. More than 90% hospitalized patients receive the IV therapy, thus contributing towards the market growth of home infusion therapy.

In January 2022, ICU Medical, a California-based global operations company, finalized the acquisition of Smiths Medical from Smiths Group Plc for creating a leading infusion therapy company with a combined revenue of USD 2.5 billion.

In November 2021, Terumo Corporation, a global medical device company, developed a smartphone device for controlling insulin pump. This device can be utilized as a home infusion therapy by patients for harmonizing the insulin therapy at home.

Order a free sample PDF of the Home Infusion Therapy Market Intelligence Study, published by Grand View Research.

[neha24blog]

Cell And Gene Therapy Clinical Trials Market Overview By Phase, Indication, Region And Forecast To 2030   : Grand View Research Inc.

San Francisco, 8 Aug 2024: The Report Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, II, III, IV), By Indication (Oncology, CNS), By Region (Asia Pacific, North America), And Segment Forecasts, 2023 – 2030 The global cell and gene therapy clinical trials market size is expected to reach USD 24521.8 million by 2030, registering a CAGR of…

[giresearch]

Positive Pressure Needle-Free Sealed Infusion Connector Market Size, Global Industry Trend Analysis and Forecast 2024-2030

On 2024-8-2, the latest report 【Global Positive Pressure Needle-Free Sealed Infusion Connector Market 2024 by Manufacturers, Regions, Types and Applications, Forecast to 2030】from Global Info Research provides a detailed and comprehensive analysis of the global Positive Pressure Needle-Free Sealed Infusion Connector market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2024.

A positive pressure needle-free sealed infusion connector is a specialized medical device designed to improve the safety and efficiency of intravenous (IV) therapy. These connectors prevent blood reflux into the catheter, reducing the risk of catheter occlusion and maintaining catheter patency without the use of needles, which minimizes the risk of needlestick injuries and contamination. According to our (Global Info Research) latest study, the global Positive Pressure Needle-Free Sealed Infusion Connector market size was valued at US$ 140 million in 2023 and is forecast to a readjusted size of USD 201 million by 2030 with a CAGR of 5.4% during review period. This report is a detailed and comprehensive analysis for global Positive Pressure Needle-Free Sealed Infusion Connector market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.

Positive Pressure Needle-Free Sealed Infusion Connector market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type： Single Channel、Dual Channel、Three Channels

Market segment by Application：Hospital、Clinic

Major players covered：BD、B. Braun、ICU Medical、Terumo Medical、Vygon、Henan Tuoren Best Medical Device、Guangdong Baihe Medical Technology、Super Health Medical、Weigao Group、JiangXi HuaLi Medical、Shenzhen Antmed、Suzhou Linhwa Medical、HaoLang Medical、Shinva Ande Healthcare、Foshan Special Medical、Beijing Fert Technology

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Positive Pressure Needle-Free Sealed Infusion Connector product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Positive Pressure Needle-Free Sealed Infusion Connector, with price, sales quantity, revenue, and global market share of Positive Pressure Needle-Free Sealed Infusion Connector from 2019 to 2024.

Chapter 3, the Positive Pressure Needle-Free Sealed Infusion Connector competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Positive Pressure Needle-Free Sealed Infusion Connector breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment Positive Pressure Needle-Free Sealed Infusion Connector the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the Positive Pressure Needle-Free Sealed Infusion Connector sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Positive Pressure Needle-Free Sealed Infusion Connector market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Positive Pressure Needle-Free Sealed Infusion Connector.

Chapter 14 and 15, to describe Positive Pressure Needle-Free Sealed Infusion Connector sales channel, distributors, customers, research findings and conclusion.

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Positive Pressure Needle-Free Sealed Infusion Connector

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.

[onlinecareerestmarket]

In-Home IV Hydration Therapy Market Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

The In-Home IV Hydration Therapy market presents a transformative approach to healthcare delivery. This innovative market caters to a growing demand for personalized and convenient intravenous hydration solutions within the comfort of one's home. IV hydration therapy, traditionally confined to clinical settings, has witnessed a paradigm shift with the advent of in-home services.

Get a Free Sample Report:https://www.metastatinsight.com/request-sample/2537

Who are the largest manufacturers of the In-Home IV Hydration Therapy Market

worldwide?

Core IV Therapy, LLC

Cryojuvenate UK Ltd.

Braun Medical Inc.

Hydration Room

NexGen Health

JW Life Science Corporation

Amanta Healthcare Ltd.

Baxter International Inc.

Drip Hydration

In recent years, the Global In-Home IV Hydration Therapy market has gained momentum due to its ability to provide efficient and tailored solutions for individuals seeking hydration, nutrient replenishment, and wellness enhancement. The market's essence lies in its capacity to offer a spectrum of intravenous therapies in a home environment, eliminating the need for patients to visit healthcare facilities for such services.

Access Full Report @https://www.metastatinsight.com/report/in-home-iv-hydration-therapy-market

One of the key drivers of the Global In-Home IV Hydration Therapy market is the increasing awareness and preference for proactive health and wellness measures. Individuals, from athletes to busy professionals, are turning to in-home IV hydration services to address fatigue, boost immune function, and achieve optimal hydration levels. The market's appeal also extends to those recovering from illness or surgery, seeking a more personalized and convenient recovery process.

Moreover, the market is characterized by a diverse range of intravenous formulations, addressing specific health concerns and goals. From electrolyte-rich solutions for rehydration to vitamin-infused blends promoting immune support and energy, the in-home IV hydration therapy market offers a nuanced approach to health optimization. This diversity in offerings contributes to the market's ability to cater to a broad spectrum of consumer needs.

Furthermore, the Global In-Home IV Hydration Therapy market has leveraged technology to streamline service delivery. Online platforms and mobile applications enable seamless scheduling, consultation with healthcare professionals, and tracking of health metrics. This integration of technology enhances the accessibility and convenience of in-home IV hydration services, making it an attractive option for health-conscious individuals.

As the market continues to evolve, collaboration between healthcare providers, technology developers, and wellness experts becomes pivotal in ensuring the highest standards of service and safety. Regulatory frameworks are adapting to accommodate the unique challenges and opportunities presented by the in-home healthcare landscape, fostering a conducive environment for the sustainable growth of the Global In-Home IV Hydration Therapy market.

The Global In-Home IV Hydration Therapy market represents a revolutionary approach to healthcare, redefining the way individuals access intravenous hydration and wellness services. With a focus on personalization, convenience, and technological integration, this market is poised to play a significant role in shaping the future of proactive and accessible healthcare delivery.

Global In-Home IV Hydration Therapy market is estimated to reach $2576.4 Million by 2031; growing at a CAGR of 13.1% from 2024 to 2031.

Contact Us:   

inquiry@metastatinsight.com

+1 214 613 5758

[wellnessweb]

Home Infusion Therapy Market Size: Current Status and Future Prospects

The Home Infusion Therapy Market was valued at 36 billion in 2023 and is expected to reach 66.63 billion by 2031 and grow at a CAGR of 8% during the forecast period of 2024-2031.The Home Infusion Therapy Market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and advancements in medical technology. This market encompasses a range of services and products, including intravenous medications, equipment, and professional care services, which allow patients to receive medical treatment in the comfort of their homes. The convenience and cost-effectiveness of home infusion therapy, coupled with the rising preference for personalized healthcare solutions, are key factors propelling its expansion. Additionally, innovations in portable infusion devices and telehealth integration are enhancing patient outcomes and safety, further boosting the market's potential.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/3021

Market Scope & Overview

The market report focuses on global consumption patterns, development trends, sales patterns, and sales in important regions and their respective countries. The market research study on Home Infusion Therapy Market covers market share, significant trends, historical and projected costs, revenue, demand and supply statistics, market growth analysis, the current regulatory environment, and its effects on significant geographic areas.

According to market research by Home Infusion Therapy Market , the market is changing quickly, and the impact is being examined in both the present and possible futures. In-depth market research is carried out, taking into account a variety of factors including the existence and business climate of a country as well as the market's unique influence.

Market Segmentation Analysis

By Product

Infusion Pumps

Intravenous Sets

IV Cannulas

Needleless Connectors

By Application

Anti-Infective

Endocrinology

Hydration Therapy

Parenteral Nutrition

Others

COVID-19 Impact Analysis

The global economy has been severely impacted by the coronavirus outbreak. This Home Infusion Therapy Market  research study also includes the most recent COVID-19 scenario analysis. The top companies in the industry, distributors, and supply chain companies in the target market are also examined in the research report.

Regional Outlook

The geographical markets for Home Infusion Therapy Market  are North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Each geographic market is examined in-depth in the market research report, which also identifies the key factors affecting the global market as a whole.

Competitive Analysis

To give readers a better understanding of key players, the research report incorporates cutting-edge research methodologies like SWOT and Porter's Five Forces analysis. Additionally, there is data on the economy, global positioning, product portfolios, revenue, gross profit margins, and technological and scientific advances. The Home Infusion Therapy Market  report focuses on the most significant business partnerships, product launches, and acquisitions.

Key Reasons to Purchase Home Infusion Therapy Market  Research Report

In-depth analysis of the global competitive landscape is provided in the research report, along with crucial details on the main rivals and their long-term growth plans.

Critical development status, growth rates, assessments of the competitive environment, and data on global marketing are all included in market research.

Conclusion

The market research report offers a dashboard overview of well-known companies, highlighting their successful marketing tactics, contributions to the industry, and most recent advancements in both historical and modern contexts.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

MicroRNA Market Trends

Neuroendoscopy Market Trends

DNA Synthesis Market Trends

Ophthalmology PACS Market Trends

Analgesics Market Trends

[marketinsight1234]

IV Therapy Market: Global Industry Analysis, Growth, Trends And Forecasts (2023 - 2030)

The Global IV Therapy Market size was reasonably estimated to be approximately USD 47560 Million in 2023 and is poised to generate revenue over USD 78900 Million by the end of 2030, projecting a CAGR of around 6.70% from 2023 to 2030.

Intravenous therapy, or IV therapy, involves injecting blood, medication, nutrients, or fluids directly into a vein. IV therapy involves the use of a needle, a small plastic tubing called a cannula that inserts into the vein, and plastic tubing that links the setup to a fluid-filled bag. The components collectively are referred to as a "IV."

Rehydrating via intravenous injection is a popular method for giving nutrients to people who are unable or unwilling to eat or drink by mouth (for example, because of diminished mental capacity).

While many therapies are administered as a "bolus" or one-time dose, they can also be administered as an extended infusion or drip. The act of administering a therapy intravenously, or placing an intravenous line ("IV line") for later use, is a procedure that should only be performed by a skilled professional. The intravenous route is the fastest way to deliver medications and fluid replacement throughout the body because they are introduced directly into the circulatory system and thus quickly distributed.

The simplest type of intravenous access is when a needle is used to puncture the skin and reach a vein, which is then connected to an external tubing or syringe. This is how the intended therapy is delivered.

Medication and fluid replacement that must be disseminated throughout the body, particularly when rapid distribution is required, are administered via intravenous (IV) access. One other application of IV therapy is to prevent the liver's first-pass metabolism.

Get Sample Report: -

Updated Version 2024 is available our Sample Report May Includes the:

Scope For 2024

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (structure of the report)

Research methodology adopted by Worldwide Market Reports

Moreover, the report includes significant chapters such as Patent Analysis, Regulatory Framework, Technology Roadmap, BCG Matrix, Heat Map Analysis, Price Trend Analysis, and Investment Analysis which help to understand the market direction and movement in the current and upcoming years.

Leading players involved in the IV Therapy Market include:

"BioScrip Inc. (US),Option Care Health Inc. (US),Coram LLC (US), BriovaRx (US), PharMerica Corporation (US), Amsino International Inc. (US), BioLife Plasma Services (US),Cigna Corporation (US),CVS Health Corporation (US),Express Scripts Holding Company (US),Diplomat Pharmacy Inc. (US),Walgreens Boots Alliance Inc. (US),AmerisourceBergen Corporation (US),Baxter International Inc. (US), B. Braun Melsungen AG (Germany), Fresenius SE & Co. KGaA (Germany),Terumo Corporation (Japan), Nipro Corporation (Japan), Smiths Medical (United Kingdom), Grifols S.A. (Spain)".

Market Driver:

One prominent driver of the IV Therapy Market is the growing aging population worldwide. As the elderly population expands, there is a corresponding increase in the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which often require long-term intravenous treatments. Additionally, the elderly are more susceptible to dehydration and nutritional deficiencies, further driving the demand for IV therapy solutions.

Market Opportunity:

An emerging opportunity within the IV Therapy Market lies in the expansion of home infusion therapy services. With advancements in technology and the development of user-friendly infusion devices, there is a growing trend towards shifting certain IV treatments from traditional healthcare settings to patients' homes. This presents a significant opportunity for healthcare providers to offer convenient, cost-effective, and personalized IV therapy options for patients, while also reducing the burden on hospitals and clinics.

If You Have Any Query IV Therapy Market Report, Visit:

Segmentation of IV Therapy Market:

By Type

Implantable Ports

Intravenous Catheters

Hypodermic Needles

Infusion Pumps

Other

By Medical Application

Volume Expander

Medication Administration

Blood Based Products

Nutrition

Buffer Solution

By End User

Hospitals

Ambulatory Surgical Center

Clinics

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Other Distribution Channels

By Regions: -

North America (US, Canada, Mexico)

Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)

Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)

Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)

Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)

South America (Brazil, Argentina, Rest of SA)

 Effective Points Covered in IV Therapy Market Report: -

Details Competitor analysis with accurate, up-to-date demand-side dynamics information.

Standard performance against major competitors.

Identify the growth segment of your investment.

Understanding most recent innovative development and supply chain pattern.

Establish regional / national strategy based on statistics.

Develop strategies based on future development possibilities. 

Purchase This Reports: -

About Us:

We are technocratic market research and consulting company that provides comprehensive and data-driven market insights. We hold the expertise in demand analysis and estimation of multidomain industries with encyclopedic competitive and landscape analysis. Also, our in-depth macro-economic analysis gives a bird's eye view of a market to our esteemed client. Our team at Pristine Intelligence focuses on result-oriented methodologies which are based on historic and present data to produce authentic foretelling about the industry. Pristine Intelligence's extensive studies help our clients to make righteous decisions that make a positive impact on their business. Our customer-oriented business model firmly follows satisfactory service through which our brand name is recognized in the market.

Contact Us:

Office No 101, Saudamini Commercial Complex,

Right Bhusari Colony,

Kothrud, Pune,

Maharashtra, India - 411038 (+1) 773 382 1049 +91 - 81800 - 96367

Email: sales@pristineintelligence.com

[amrutatbrc1]

Intravenous Infusion Pumps Market By Product Type, By Manufacturers, By End-User And Market Trend Analysis Forecast 2033

The intravenous infusion pumps global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Intravenous Infusion Pumps Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The intravenous infusion pumps market size has grown strongly in recent years. It will grow from $5.71 billion in 2023 to $6.15 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to advances in medical technology, aging population, home healthcare services, hospital and healthcare facility expansion, regulatory standards.

The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to $8.51 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing chronic disease burden, technological innovation, home infusion services, telehealth and remote monitoring. Major trends in the forecast period include smart infusion pumps, wireless and remote monitoring, home infusion therapy, precision medicine and personalized infusion.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - The rise in the prevalence of people with chronic pain, cancer, and diabetes is a significant driver of the demand for intravenous infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, which can be attributed to an aging population and shifts in social behavior that led to a gradual increase of these widespread and expensive long-term medical issues. Infusion pumps are used to transfer regulated doses of nutrients or drugs into a patient's body, such as chemotherapy medicines, pain relievers, antibiotics, insulin, or other hormones. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based autonomous statutory agency tasked with obtaining and analyzing data and making factual recommendations to local, national, and territorial governments, almost fifty percent of the population (46.6%, or 11.6 million) suffered from at least one chronic illness. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the intravenous infusion pumps market.

The intravenous infusion pumps market covered in this report is segmented –

1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products 2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications 3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users

Get an inside scoop of the intravenous infusion pumps market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3305&type=smp

Regional Insights - North America was the largest region in the intravenous infusion pumps market in 2023. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies - Major companies operating in the intravenous infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Boston Scientific Corporation, Pfizer Inc., Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation

Table of Contents 1. Executive Summary 2. Intravenous Infusion Pumps Market Report Structure 3. Intravenous Infusion Pumps Market Trends And Strategies 4. Intravenous Infusion Pumps Market – Macro Economic Scenario 5. Intravenous Infusion Pumps Market Size And Growth ….. 27. Intravenous Infusion Pumps Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[bizworldinsights]

Osteoarthritis

In 2019, the global osteoarthritis market is estimated to be valued at over US$ 2,205 million, projecting a robust CAGR of 9.1% from 2019 to 2028. This marks a significant 2.2X increase in revenue opportunity by 2028 compared to 2018. The industry landscape is characterized by consolidation, with major players heavily invested in R&D endeavors, particularly focused on the development of cell-mediated drugs. A transformative shift is anticipated as a considerable number of clinical trials progress into phases III and IV.

To read more about the topic please visit site : https://bekryl.com/industry-trends/osteoarthritis-market-share-analysis

Key Trends and Drivers Fueling Osteoarthritis Market Demand:

The prevalence of osteoarthritis cases has surged over the last decade, reaching over 316 million cases globally in 2019. Projections indicate an increase to 381 million cases by 2028. This rise in cases is driving the demand for effective treatment options, predominantly in medicated forms.

The competitive landscape is expected to intensify in the latter part of the forecast period (post-2024). The majority of products are currently under trial in phase II of FDA testing. Upon approval, this will lead to heightened competition, significantly impacting the market share of key players. Approximately half of the products are undergoing phase III and IV trials, with a concentration of clinical trials in North America, followed by Western Europe. Japan and South Korea are pivotal regions in Asia Pacific, witnessing clinical trials evaluating product efficacy. Pfizer stands out with the highest number of clinical trials and dominated the osteoarthritis market share in 2018.

Merger and acquisition activities are expected to be a prominent trend in the market. The heightened competition will drive companies to acquire the technological and market competencies of established players. Notably, in 2018, Mundipharma strategically collaborated with Kolon Life Sciences to market Invossa®-K in Saudi Arabia and the United Arab Emirates, with subsequent extension to Japan. Invossa®-K, the world's first cell-mediated gene therapy for osteoarthritis, received approval in 2017 from the Korean Ministry of Food and Drug Safety (MFDS).

Global Osteoarthritis Market Size, Segment Analysis:

Drug Class: Corticosteroids, NSIADs, and Viscosupplementation Agents contribute to industry revenue. Viscosupplementation is expected to witness the highest growth during the forecast period.

Route of Administration: The market revenue for osteoarthritis drugs is analyzed based on oral drugs, parenteral drugs, and topical drugs. Oral-based OA drugs held the highest share in 2018 and are anticipated to maintain this trend throughout the forecast period.

Distribution Channel: Revenue analysis spans hospitals, drugstores, pharmacies, and online channels. While online channels held the lowest share, they are projected to experience double-digit growth. Major players are actively investing in online channels to enhance purchasing convenience for customers and foster long-term retention.

Global Osteoarthritis Market Size, Regional Outlook:

North America: Witnessed the highest osteoarthritis drug sales in 2018, contributing to 57% of total market revenue. With over 61 million people in the U.S. suffering from OA, the region provides a sizable addressable market. The U.S. sees robust sales of biologic analgesics such as Regeneron’s fasinumab, TissueGene’s Invossa, and Pfizer’s tanezumab.

Asia Pacific: Expected to register the fastest growth during the forecast period. Japan and China hold the highest OA market share in 2019, with Japan's market valued at US$ 169 million in 2018. China and India are projected to achieve double-digit growth due to increased healthcare FDI and improved healthcare infrastructure. Favorable reimbursement policies, such as India's Ayushman Bharat, are poised to make healthcare more accessible to lower-income individuals, boosting spending on osteoarthritis treatment in the region.

Global Osteoarthritis Market Size, Competitive Landscape:

Key industry players include Pfizer, Cara Therapeutics, Mitsubishi Tanabe Pharma, Ampio Pharmaceuticals, Cellular Biomedicine Group, Teva Pharmaceutical, Eli Lilly, Techfields Pharma, Healthcare Life Sciences, Seikagaku Corp, Kolon Life Sciences, Flexion Therapeutics, Ono Pharmaceutical, Regeneron Pharmaceuticals, Mundipharma, Samumed, Centrexion Therapeutics, TissueGene, among others.

Research Scope:

By Drug Class:

Corticosteroids

NSIADs

Viscosupplementation Agents

By Route of Administration:

Oral

Parenteral

Topical

By Distribution Channel:

Drugstores

Pharmacies

Hospital Stores

Online Pharmacies

The global osteoarthritis market is poised for substantial growth, driven by escalating cases, evolving clinical trials, and significant advancements in treatment options. As the industry progresses into higher phases of FDA testing, competition will heighten, creating a dynamic landscape. Emerging markets, particularly in Asia Pacific, are expected to play a pivotal role in shaping the future of osteoarthritis treatment, presenting lucrative opportunities for industry players.

[omkarpatel]

Butterfly Needles are Estimated to Witness High Growth Owing to Rising Prevalence of Chronic Diseases

Butterfly needles, also known as winged infusion needles, are specially designed intravenous (IV) insertion needles that have small plastic "wings" mounted on the shaft of the needle hub. These wings prevent accidental needle sticks and help secure and properly position the needle during venous access. Butterfly needles are commonly used for venipuncture, especially for blood specimen collection or IV access. They minimize procedure time and discomfort for patients by preventing multiple needle sticks. The global butterfly needles market is estimated to be valued at US$ 2.16 Bn in 2024 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The rising prevalence of chronic diseases is estimated to drive the growth of the butterfly needles market. Chronic diseases such as cancer, cardiovascular diseases, diabetes, and respiratory diseases have significant impacts on morbidity, mortality as well as healthcare expenditures worldwide. For instance, according to the World Health Organization (WHO), chronic diseases are estimated to account for approximately 60% of all deaths globally. Treatment of chronic diseases often requires multiple venipuncture procedures and intravenous therapies over long periods. This is expected to increase the demand for butterfly needles as they minimize discomfort to patients during such repeated needle insertion procedures. Thus, the growing burden of chronic diseases is anticipated to create lucrative opportunities for the butterfly needles market over the forecast period. Porter's Analysis Threat of new entrants: The butterfly needles market has moderate threat of new entrants due to high capital requirements for manufacturing and distribution infrastructure. However, new innovative offerings may appeal to customers. Bargaining power of buyers: Buyers have moderate bargaining power in this market due to availability of substitutes like intravenous catheters. However, brand loyalty and low switching costs keep buyer power in check. Bargaining power of suppliers: A few major players dominate the supply side, giving them significant power over buyers. However, availability of alternative raw material sources prevents excessive exploitation. Threat of new substitutes: Substitutes like intravenous catheters pose moderate threat. However, ease of use makes butterfly needles irreplaceable for many small-scale procedures. Competitive rivalry: The market sees close competition between major players to gain market share through innovative product expansions. SWOT Analysis Strengths: High patient compliance due to compact size and painless insertion. Training for usage is also easier compared to other access devices. Weaknesses: Requires trained healthcare professionals for application. Improper sterility measures can introduce infections. Opportunities: Growing prevalence of chronic diseases will boost demand. Untapped developing markets have considerable potential. Threats: Stringent regulatory approvals delay product launches. Supply chain disruptions due to pandemic affect availability. Key Takeaways The global Butterfly Needles market is expected to witness high growth over the forecast period of 2023 to 2030. The market size for 2024 is projected to reach US$ 2.16 Bn registering a CAGR of 8.7%. Regional analysis indicates North America will continue dominating the butterfly needles market, driven by advanced healthcare infrastructure and high awareness. Asia Pacific is poised to grow at the fastest pace due to rising medical tourism and improvements in healthcare systems across Asian countries. Key players operating in the butterfly needles market are Alshifa Medical Syringes, Asahi Kasei Medical, Cardinal Health, Medicina, Medline Industries, Narang Medical, pfm medical, Retractable Technologies, and Winnomed. Most players are focusing on expanding their product portfolios through innovative technologies to capture larger shares.

[latestmarketresearchreports]

IV Fluid Monitoring Devices Market Growth, Size, Share, Trends - Forecast and Analysis 2020-2024

IV Fluid Monitoring Devices Market will register a CAGR of 7% during 2020-2024. The market’s growth momentum will Decelerate.

increase in number of hospitalizations will be one of the major factors driving the growth of this market. Additionally, key IV Fluid Monitoring Devices Market trends such as the emergence of smart infusion therapy devices will also influence market growth during the forecast period.

IV Fluid Monitoring Devices Market Size

Get a FREE sample for more insights on the growth and the market share of various regions

During the forecast period, the IV Fluid Monitoring Devices Market size will grow by USD 1.21 bn.

IV Fluid Monitoring Devices Market : Vendors

The market is concentrated and owing to the growth opportunities, the level of competition among the companies in this market space will intensify further. are some of the major companies in the IV Fluid Monitoring Devices Market. Though the forecast period offers opportunities for vendors to increase their market share, factors such as the  will also challenge the growth of the companies.

B. Braun Melsungen AG | Baxter International Inc. | Becton, Dickinson and Co. | Fortive Corp. | ICU Medical Inc. | IRadimed Corp. | Micrel Medical Devices SA | Seaward Electronic Ltd. | Shift Labs Inc. | Sino Medical-Device Technology Co. Ltd..list

are some of the companies covered in Technavio’s IV Fluid Monitoring Devices Market report for 2020-2024.

IV Fluid Monitoring Devices Market : Region-level Analysis

The report identifies region-level market dynamics, developments, and key markets. The regional level analysis also identifies the market share, growth momentum, and key leading countries in the IV Fluid Monitoring Devices Market.

The North America will account for the largest IV Fluid Monitoring Devices Market share and during 2020-2024, the region will contribute to 32% of the market’s growth.

In addition to regions and the key companies involved, Technavio’s IV Fluid Monitoring Devices Market report also analyzes the market by Hospitals and clinics | ASCs | Home care | North America | Europe | Asia | ROW.comma

Our Custom Research Solutions can provide tailored IV Fluid Monitoring Devices Market information to meet your specific requirements.

[technavio]

COVID-19 Impact and Recovery Analysis - Global IV Fluid Monitoring Devices Market 2020-2024 | Evolving Opportunities with B. Braun Melsungen AG and Baxter International Inc. | Technavio

The global IV fluid monitoring devices market is expected to grow by USD 1,210.92 million as per Technavio. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic.

Request for Technavio's latest reports on directly and indirectly impacted markets

Market estimates include pre- and post-COVID-19 impact on the IV fluid monitoring devices market - Request free sample pages

The global IV fluid monitoring devices market is expected to witness an upsurge due to the spread of COVID-19. The extension of containment efforts is leading to increased demand, which is leading to higher revenue growth for market players. Also, the prices are expected to remain elevated for the short term due to lower production caused by shutdowns.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

https://www.technavio.com/report/iv-fluid-monitoring-devices-market-industry-analysis

The market is driven by an increase in the number of hospitalizations. In addition, the emergence of smart infusion therapy devices is anticipated to boost the growth of the IV fluid monitoring devices market.

The growing global population and the rising prevalence of various acute and chronic diseases have increased the number of hospitalizations across the world. For instance, in 2018, about seven out of 10 people in the US had at least one chronic disease such as cancer, heart disease, stroke, and diabetes. In addition, the rapid spread of the COVID-19 pandemic has increased the need for intravenous access devices which are crucial in providing medication and fluids to hospitalized patients. Also, the high influx of patients increases the chances of errors in monitoring fluid transfusions. Hence, end-users are increasingly adopting IV monitoring devices to ensure patient safety. These devices use IR sensors, RF transmitters, receivers, and buzzers to inform the control room either to change the intravenous set or to switch it off. With the rising number of hospitalizations, the growth of the global IV fluid monitoring devices market will gain momentum during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five IV Fluid Monitoring Devices Companies:

B. Braun Melsungen AG

B. Braun Melsungen AG operates its business through segments such as B. Braun Hospital Care, B. Braun Aesculap, B. Braun Out Patient Market, and B. Braun Avitum. The company offers various automated infusion systems such as Perfusor Space, Infusomat space, and SpaceControl.

Baxter International Inc.

Baxter International Inc. operates its business through segments such as the Americas, EMEA, and APAC. The company offers a wide range of IV fluid monitoring devices. Some of its key offerings include Spectrum IQ Infusion System and Baxter FloGard 6201.

Becton, Dickinson and Co.

Becton, Dickinson and Co. operate its business through segments such as BD Medical, BD Life Sciences, and BD Interventional. The company offers BD Alaris Pump Module. It is a large volume infusion pump that continuously or intermittently delivers fluids, medications, blood and blood products to adult, pediatric, and neonatal patients.

Fortive Corp.

Fortive Corp. operates its business through segments such as Professional Instrumentation and Industrial Technologies. The company offers IDA-1S Analyzer through its subsidiary, Fluke Biomedical. It is a portable, high-performance infusion device analyzer designed for on-the-go testing.

ICU Medical Inc.

ICU Medical Inc. operates its business through a unified segment. The company offers the Plum 360 Infuser. It is a large volume infuser capable of delivering fluids for a variety of therapies such as parenteral, enteral, or epidural infusions. The Plum 360 infuser can deliver fluids over a broad range of infusion rates and is capable of Concurrent delivery from one or more rigid or flexible fluid containers

IV Fluid Monitoring Devices Market End-user Outlook (Revenue, USD Million, 2020-2024)

Hospitals and clinics

ASCs

Home care

IV Fluid Monitoring Devices Market Geographic Outlook (Revenue, USD Million, 2020-2024)

North America

Europe

Asia

ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Request a free sample report